LNA Sante SA (0OR2) Share Forecast & Price Target
0OR2 Analyst Ratings
There are no analyst ratings in the last 3 months.
0OR2 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Cerdan | Kepler Capital | EUR 35→EUR 42 | buy | 74.27%Upside | Reiterated | 05/20/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Cerdan | 05/20/26 | EUR 35→EUR 42 | buy | 74.27%Upside | Reiterated | Kepler Capital |
Best Analysts Covering LNA Sante SA
Copying David Cerdan's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +6.22% per trade.
Copying David Cerdan's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +4.91% per trade.
Copying David Cerdan's trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -7.17% per trade.
0OR2 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 0 | 0 | 0 |
In the current month, 0OR2 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0OR2 average Analyst price target in the past 3 months is ―.
0OR2 Financial Forecast
0OR2 Earnings Forecast
Next quarter’s earnings estimate for 0OR2 is EUR 1.22 with a range of ― to ―. The previous quarter’s EPS was EUR 1.22. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
0OR2 Sales Forecast
Next quarter’s sales forecast for 0OR2 is EUR 484.02M with a range of ― to ―. The previous quarter’s sales results were EUR 484.02M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.